Title
Category
Credits
Event date
Cost
  • ALAHOPE Substance Use
  • 0.30 ABN
  • 0.25 ABSWE
  • 0.25 ACPE Pharmacy
  • 0.25 AMA PRA Category 1 Credit™
  • 0.25 Attendance
  • 0.25 BDEA
$0.00
An interactive, online training session regarding antidotes for responding to an overdose.
  • ALAHOPE Substance Use
  • 0.30 ABN
  • 0.25 ABSWE
  • 0.25 ACPE Pharmacy
  • 0.25 AMA PRA Category 1 Credit™
  • 0.25 Attendance
  • 0.25 BDEA
$0.00
An interactive, online training session regarding the neurology and neurobiology components of substance use disorder along with explaining the similarities between substance use disorder and chronic disease.
  • ALAHOPE Substance Use
  • 0.30 ABN
  • 0.25 ABSWE
  • 0.25 ACPE Pharmacy
  • 0.25 AMA PRA Category 1 Credit™
  • 0.25 Attendance
  • 0.25 BDEA
$0.00
An interactive, online training session regarding overdose risk factors, signs, and response around opioids and related drugs.
  • ALAHOPE Substance Use
  • 0.30 ABN
  • 0.25 ABSWE
  • 0.25 ACPE Pharmacy
  • 0.25 AMA PRA Category 1 Credit™
  • 0.25 Attendance
  • 0.25 BDEA
$0.00
An interactive, online training session explaining co-occurring conditions that often coincide with substance use disorder.
  • ALAHOPE Substance Use
  • 0.30 ABN
  • 0.25 ABSWE
  • 0.25 ACPE Pharmacy
  • 0.25 AMA PRA Category 1 Credit™
  • 0.25 Attendance
  • 0.25 BDEA
$0.00
An interactive, online training session explaining the assessment, diagnosis, and risk factors of substance use disorder.
  • ALAHOPE Substance Use
  • 0.60 ABN
  • 0.50 ABSWE
  • 0.50 ACPE Pharmacy
  • 0.50 AMA PRA Category 1 Credit™
  • 0.50 Attendance
  • 0.50 BDEA
$0.00
An interactive, online training session regarding treating opioid use disorder with FDA approved medications along with common challenges found during such treatment.
  • Brookwood Baptist Health CE
  • 1.20 ABN
  • 1.00 ABSWE
04/18/2024
$0.00
Within the healthcare setting, nurses play a crucial role in assisting patients with asthma, in managing their inhaler therapy. However, these nurses may also notice that patients with severe asthma may be on new monoclonal antibody therapy. It is important to understand the administration, potential side effects, and clinical considerations for managing these medications to increase their knowledge about the medications these patients are taking.  

Pages